No Data
No Data
No Data
No Data
No Data
Buy Rating Affirmed for PAVmed on Growth and Valuation Prospects Amidst Product Commercialization
TipRanksApr 15 05:16 ET
Express News | PAVmed Inc : Ascendiant Capital Markets Cuts Target Price to $26 From $30
Moomoo 24/7Apr 14 23:04 ET
Why PAVmed Inc. (PAVM) Dipped More Than Broader Market Today
Yahoo FinanceApr 10 18:15 ET
Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and...
PR NewswireApr 8 08:30 ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersAvalo Therapeutics (NASDAQ:AVTX) stock rose 289.1% to $18.48 during Friday's pre-market session. The market value of their outstanding shares is at $14.8 million. Xilio Therapeutics (NASDAQ:XLO
BenzingaMar 29 08:06 ET
Buy Rating Affirmed for PAVmed With Strategic Focus on Lucid Diagnostics and Veris Cancer Care Amid Adjusted Price Target
TipRanksMar 29 07:46 ET
No Data
No Data